Retrospective study comparing anti‐EGFR monoclonal antibody plus cisplatin‐based chemoradiotherapy versus chemoradiotherapy alone for stage II‐IVb nasopharyngeal carcinoma and prognostic value of EGFR and VEGF expression
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Otolaryngology"
DOI: 10.1111/coa.13340
Abstract: The benefits of adding anti‐EGFR therapy to conventional chemoradiotherapy (CRT) for nasopharyngeal carcinoma (NPC) remain uncertain, possibly because only a subgroup of patients show better outcome. To address this issue, we compared the efficacy of… read more here.
Keywords: stage ivb; chemoradiotherapy; anti egfr; alone stage ... See more keywords